Non-Insulin Novel Antidiabetic Drugs Mechanisms in the Pathogenesis of COVID-19

Non-Insulin Novel Antidiabetic Drugs Mechanisms in the Pathogenesis of COVID-19

The present study aimed to analyse the published data and to realize an update about the use and pathogenesis of the novel antidiabetic drugs, respectively, dipeptidyl peptidase-4 inhibitors (DPP-4i), glucagon-like peptide-1 receptor agonists (GLP-1 Ra), and sodium-glucose co-transporter-2 inhibitor...

Full description

Bibliographic Details
Main Authors: Teodor Salmen, Valeria-Anca Pietroșel, Bianca-Margareta Mihai, Ioana Cristina Bica, Claudiu Teodorescu, Horia Păunescu, Oana Andreia Coman, Doina-Andrada Mihai, Anca Pantea Stoian
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Biomedicines
Subjects:
dipeptidyl peptidase-4 inhibitors
glucagon-like peptide-1 receptor agonist
sodium-glucose co-transporter-2 inhibitors
COVID-19
pathogenesis
Online Access:https://www.mdpi.com/2227-9059/10/10/2624

Internet

https://www.mdpi.com/2227-9059/10/10/2624

Similar Items